Dagmar Stropova

991 total citations
39 papers, 780 citations indexed

About

Dagmar Stropova is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Dagmar Stropova has authored 39 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cellular and Molecular Neuroscience, 33 papers in Molecular Biology and 5 papers in Animal Science and Zoology. Recurrent topics in Dagmar Stropova's work include Neuropeptides and Animal Physiology (33 papers), Receptor Mechanisms and Signaling (26 papers) and Chemical Synthesis and Analysis (12 papers). Dagmar Stropova is often cited by papers focused on Neuropeptides and Animal Physiology (33 papers), Receptor Mechanisms and Signaling (26 papers) and Chemical Synthesis and Analysis (12 papers). Dagmar Stropova collaborates with scholars based in United States, Poland and Japan. Dagmar Stropova's co-authors include Henry I. Yamamura, Éva Varga, William R. Roeske, Victor J. Hruby, Frank Porreca, Peg Davis, Edita Navratilova, Richard D. Egleton, Teresa Zalewska and Jason D. Huber and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Dagmar Stropova

38 papers receiving 760 citations

Peers

Dagmar Stropova
Yeon Sun Lee United States
Dagmar Stropova
Citations per year, relative to Dagmar Stropova Dagmar Stropova (= 1×) peers Yeon Sun Lee

Countries citing papers authored by Dagmar Stropova

Since Specialization
Citations

This map shows the geographic impact of Dagmar Stropova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Stropova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Stropova more than expected).

Fields of papers citing papers by Dagmar Stropova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Stropova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Stropova. The network helps show where Dagmar Stropova may publish in the future.

Co-authorship network of co-authors of Dagmar Stropova

This figure shows the co-authorship network connecting the top 25 collaborators of Dagmar Stropova. A scholar is included among the top collaborators of Dagmar Stropova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagmar Stropova. Dagmar Stropova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Navratilova, Edita, Sue Waite, Dagmar Stropova, et al.. (2007). Quantitative Evaluation of Human δ Opioid Receptor Desensitization Using the Operational Model of Drug Action. Molecular Pharmacology. 71(5). 1416–1426. 15 indexed citations
2.
Varga, Éva, et al.. (2006). Chronic morphine-mediated adenylyl cyclase superactivation is attenuated by the Raf-1 inhibitor, GW5074. European Journal of Pharmacology. 540(1-3). 57–59. 20 indexed citations
3.
Navratilova, Edita, Dagmar Stropova, Éva Varga, et al.. (2005). Morphine promotes phosphorylation of the human δ-opioid receptor at serine 363. European Journal of Pharmacology. 519(3). 212–214. 11 indexed citations
4.
Varga, Éva, et al.. (2004). Agonist-specific regulation of the δ-opioid receptor. Life Sciences. 76(6). 599–612. 34 indexed citations
5.
Varga, Éva, Dagmar Stropova, Victor J. Hruby, et al.. (2003). Converging Protein Kinase Pathways Mediate Adenylyl Cyclase Superactivation upon Chronic δ-Opioid Agonist Treatment. Journal of Pharmacology and Experimental Therapeutics. 306(1). 109–115. 41 indexed citations
6.
Navratilova, Edita, et al.. (2003). Mutation S363A in the human δ-opioid receptor selectively reduces down-regulation by a peptide agonist. European Journal of Pharmacology. 485(1-3). 341–343. 4 indexed citations
7.
Varga, Éva, et al.. (2002). Involvement of Raf-1 in chronic δ-opioid receptor agonist-mediated adenylyl cyclase superactivation. European Journal of Pharmacology. 451(1). 101–102. 41 indexed citations
9.
Hosohata, Yoshiaki, Éva Varga, Dagmar Stropova, et al.. (2001). Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein activation. Life Sciences. 68(19-20). 2233–2242. 10 indexed citations
11.
Lipkowski, Andrzej W., Aleksandra Misicka, Peg Davis, et al.. (1999). Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalin. Bioorganic & Medicinal Chemistry Letters. 9(18). 2763–2766. 37 indexed citations
12.
Varga, Éva, et al.. (1999). Phosphorylation of adenylyl cyclase VI upon chronic δ-opioid receptor stimulation. European Journal of Pharmacology. 364(2-3). R1–R3. 29 indexed citations
13.
Varga, Éva, Dagmar Stropova, Man Wang, et al.. (1998). Identification of adenylyl cyclase isoenzymes in CHO and B82 cells. European Journal of Pharmacology. 348(2-3). R1–R2. 46 indexed citations
14.
Burkey, Thomas H., Frederick J. Ehlert, Yoshiaki Hosohata, et al.. (1998). The efficacy of δ-opioid receptor-selective drugs. Life Sciences. 62(17-18). 1531–1536. 13 indexed citations
15.
Davis, Peg, et al.. (1997). Opioid Peptides: Simultaneous δ Agonism and μ Antagonism in Somatostatin Analogues. Peptides. 18(1). 93–100. 13 indexed citations
16.
Hruby, Victor J., Peg Davis, Jiřina Slaninová, et al.. (1997). Cyclic Enkephalin Analogues with Exceptional Potency and Selectivity for δ-Opioid Receptors. Journal of Medicinal Chemistry. 40(24). 3957–3962. 34 indexed citations
17.
Misicka, Aleksandra, et al.. (1996). Synthesis and biological properties of gamma-glutamyl-dermorphin, a prodrug. Life Sciences. 58(11). 905–911. 17 indexed citations
18.
Qian, Xinhua, Subo Liao, Dagmar Stropova, Henry I. Yamamura, & Victor J. Hruby. (1996). Novel scaffolds for non-peptide mimetics of δ opioid receptor agonists based on peptide leads. Regulatory Peptides. 65(1). 79–82. 4 indexed citations
19.
Meyer, Jean‐Philippe, Guigen Li, Bih‐Show Lou, et al.. (1995). Highly .kappa. receptor-selective dynorphin A analogs with modifications in position 3 of dynorphin A(1-11)-NH2. Journal of Medicinal Chemistry. 38(4). 585–586. 17 indexed citations
20.
Malatyńska, Ewa, Richard J. Knapp, Dagmar Stropova, Éva Varga, & Henry I. Yamamura. (1995). The role of the Val353 residue in antagonist binding to rat CCK-B receptors. Neuroreport. 6(9). 1325–1329. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026